Marine Drugs,
Journal Year:
2018,
Volume and Issue:
16(2), P. 67 - 67
Published: Feb. 20, 2018
The
genus
Streptomyces
produces
secondary
metabolic
compounds
that
are
rich
in
biological
activity.
Many
of
these
genetically
encoded
by
large
metabolism
biosynthetic
gene
clusters
(smBGCs)
such
as
polyketide
synthases
(PKS)
and
non-ribosomal
peptide
synthetases
(NRPS)
which
modular
can
be
highly
repetitive.
Due
to
the
repeats,
difficult
resolve
using
short
read
next
generation
datasets
often
quite
poorly
predicted
standard
approaches.
We
have
sequenced
genomes
13
spp.
strains
isolated
from
shallow
water
deep-sea
sponges
display
antimicrobial
activities
against
a
number
clinically
relevant
bacterial
yeast
species.
Draft
been
assembled
smBGCs
identified
antiSMASH
(antibiotics
Secondary
Metabolite
Analysis
Shell)
web
platform.
compared
amongst
search
for
novel
sequences
conferring
potential
produce
bioactive
metabolites.
this
study
recruit
four
distinct
clades
within
Streptomyces.
marine
host
abundant
encode
polyketides,
NRPS,
siderophores,
bacteriocins
lantipeptides.
appear
enriched
with
encoding
NRPS.
Marine
adaptations
evident
sponge-derived
genes
involved
biosynthesis
transport
compatible
solutes
heat-shock
proteins.
environments
promising
source
metabolites
abundance
diversity
show
high
degrees
novelty.
Sponge
derived
isolates
genomic
living
when
terrestrial
strains.
Natural Product Reports,
Journal Year:
2015,
Volume and Issue:
32(2), P. 116 - 211
Published: Jan. 1, 2015
This
review
of
marine
natural
products
for
2013
describes
1137
new
compounds
and
reports
structural
revisions
assignments
absolute
configurations
previously
described
compounds.
Included
is
a
report
the
anticancer
sponge
metabolite
PM060184
that
has
undergone
remarkably
rapid
development
from
discovery
in
2005
to
commencement
phase
I
clinical
trials
2011.
Marine Drugs,
Journal Year:
2019,
Volume and Issue:
17(5), P. 249 - 249
Published: April 26, 2019
Rare
actinomycetes
are
prolific
in
the
marine
environment;
however,
knowledge
about
their
diversity,
distribution
and
biochemistry
is
limited.
Marine
rare
represent
a
rather
untapped
source
of
chemically
diverse
secondary
metabolites
novel
bioactive
compounds.
In
this
review,
we
aim
to
summarize
present
on
isolation,
natural
product
discovery
reported
from
mid-2013
2017.
A
total
97
new
species,
representing
9
genera
belonging
27
families
have
been
reported,
with
highest
numbers
isolates
Pseudonocardiaceae,
Demequinaceae,
Micromonosporaceae
Nocardioidaceae.
Additionally,
study
reviewed
167
compounds
produced
by
58
different
actinomycete
species
24
genera.
Most
antibacterial,
antifungal,
antiparasitic,
anticancer
or
antimalarial
activities.
The
products
were
derived
Nocardiopsis,
Micromonospora,
Salinispora
Pseudonocardia.
Members
genus
Micromonospora
revealed
be
richest
unique
products.
Journal of Genetic Engineering and Biotechnology,
Journal Year:
2022,
Volume and Issue:
20(1), P. 14 - 14
Published: Jan. 26, 2022
The
marine
environment
hosts
a
wide
variety
of
species
that
have
evolved
to
live
in
harsh
and
challenging
conditions.
Marine
organisms
are
the
focus
interest
due
their
capacity
produce
biotechnologically
useful
compounds.
They
promising
biocatalysts
for
new
sustainable
industrial
processes
because
resistance
temperature,
pH,
salt,
contaminants,
representing
an
opportunity
several
biotechnological
applications.
Encouraged
by
extensive
richness
environment,
organisms’
role
developing
therapeutic
benefits
is
heading
as
arable
field.
There
currently
much
biologically
active
compounds
derived
from
natural
resources,
especially
can
efficiently
act
on
molecular
targets,
which
involved
various
diseases.
Studies
focused
bacteria
fungi,
isolated
sediments,
seawater,
fish,
algae,
most
invertebrates
such
sponges,
mollusks,
tunicates,
coelenterates,
crustaceans.
In
addition
macro-organisms,
or
corals,
fungi
been
shown
novel
secondary
metabolites
(SMs)
with
specific
intricate
chemical
structures
may
hold
key
production
drugs
leads.
known
rich
source
numerous
beneficial
health
effects.
Presently,
lines
studies
provided
insight
into
biological
activities
neuroprotective
effects
including
antioxidant,
anti-neuroinflammatory,
cholinesterase
inhibitory
activity,
neuronal
death
inhibition.
application
marine-derived
bioactive
has
gained
importance
uses
products
(MNPs)
display
pharmaceutically
significant
bioactivities,
antibiotic,
antiviral,
neurodegenerative,
anticancer,
anti-inflammatory
properties.
present
review
focuses
critical
different
diseases
highlights
possible
contribution
humanity.
Frontiers in Microbiology,
Journal Year:
2018,
Volume and Issue:
9
Published: Aug. 8, 2018
Actinobacteria
are
wide
spread
in
nature
and
represent
the
largest
taxonomic
group
within
domain
Bacteria.
They
abundant
soil
have
been
extensively
explored
for
their
therapeutic
applications.
This
versatile
of
bacteria
has
adapted
to
diverse
ecological
habitats,
which
drawn
considerable
attention
scientific
community
recent
times
as
it
opened
up
new
possibilities
novel
metabolites
that
may
help
solving
some
most
challenging
problems
day,
example,
drugs
drug-resistant
human
pathogens,
affordable
means
maintain
balance
various
habitats
alternative
practices
sustainable
agriculture.
Traditionally,
free
dwelling
actinobacteria
subject
intensive
research.
Of
late,
symbiotic
residing
endophytes
plant
tissues
generated
immense
interest
potential
source
compounds,
find
applications
medicine,
agriculture
environment.
In
light
these
possibilities,
this
review
focuses
on
diversity
endophytic
isolated
from
plants
extreme
specific
niches.
Furthermore,
an
attempt
made
assign
chemical
class
compounds
obtained
actinobacteria.
Potential
utility
environment
discussed.
Frontiers in Marine Science,
Journal Year:
2021,
Volume and Issue:
8
Published: March 16, 2021
Coastal
countries
have
traditionally
relied
on
the
existing
marine
resources
(e.g.,
fishing,
food,
transport,
recreation,
and
tourism)
as
well
tried
to
support
new
economic
endeavors
(ocean
energy,
desalination
for
water
supply,
seabed
mining).
Modern
societies
lifestyle
resulted
in
an
increased
demand
dietary
diversity,
better
health
well-being,
biomedicines,
natural
cosmeceuticals,
environmental
conservation,
sustainable
energy
sources.
These
societal
needs
stimulated
interest
of
researchers
diverse
underexplored
environments
promising
sources
biomolecules
biomass,
they
are
addressed
by
emerging
field
(blue)
biotechnology.
Blue
biotechnology
provides
opportunities
a
wide
range
initiatives
commercial
pharmaceutical,
biomedical,
cosmetic,
nutraceutical,
feed,
agricultural,
related
industries.
This
article
synthesizes
essence,
opportunities,
responsibilities,
challenges
encountered
outlines
attainment
valorization
directly
derived
or
bio-inspired
products
from
organisms.
First,
concept
bioeconomy
is
introduced.
Then,
diversity
bioresources
including
overview
most
prominent
organisms
their
potential
biotechnological
uses
described.
followed
introducing
methodologies
exploration
these
main
use
case
scenarios
food
agronomy,
bioremediation
climate
change,
materials,
healthcare,
well-being
sectors.
The
key
aspects
fields
legislation
funding
provided,
with
emphasis
importance
communication
stakeholder
engagement
at
all
levels
development.
Finally,
vital
overarching
concepts,
such
quadruple
helix
Responsible
Research
Innovation
principle
highlighted
important
follow
within
field.
authors
this
review
collaborating
under
European
Commission-funded
Cooperation
Science
Technology
(COST)
Action
Ocean4Biotech
–
transdisciplinary
networking
platform
focus
study
state
affairs.
Molecules,
Journal Year:
2023,
Volume and Issue:
28(15), P. 5915 - 5915
Published: Aug. 6, 2023
Actinomycetes
inhabit
both
terrestrial
and
marine
ecosystems
are
highly
proficient
in
producing
a
wide
range
of
natural
products
with
diverse
biological
functions,
including
antitumor,
immunosuppressive,
antimicrobial,
antiviral
activities.
In
this
review,
we
delve
into
the
life
cycle,
ecology,
taxonomy,
classification
actinomycetes,
as
well
their
varied
bioactive
metabolites
recently
discovered
between
2015
2023.
Additionally,
explore
promising
strategies
to
unveil
investigate
new
metabolites,
encompassing
genome
mining,
activation
silent
genes
through
signal
molecules,
co-cultivation
approaches.
By
presenting
comprehensive
up-to-date
hope
offer
potential
solution
uncover
novel
compounds
essential
Antibiotics,
Journal Year:
2018,
Volume and Issue:
7(2), P. 44 - 44
Published: May 22, 2018
Actinomycetes
have
been
proven
to
be
an
excellent
source
of
secondary
metabolites
for
more
than
half
a
century.
Exhibiting
various
bioactivities,
they
provide
valuable
approved
drugs
in
clinical
use.
Most
microorganisms
are
still
untapped
terms
their
capacity
produce
metabolites,
since
only
small
fraction
can
cultured
the
laboratory.
Thus,
improving
cultivation
techniques
extend
range
metabolite
producers
accessible
under
laboratory
conditions
is
important
first
step
prospecting
underexplored
sources
isolation
novel
antibiotics.
Currently
uncultured
actinobacteria
made
available
by
bioprospecting
extreme
or
simply
habitats
other
soil.
Furthermore,
bioinformatic
analysis
genomes
reveals
most
harbour
many
biosynthetic
gene
clusters
compounds
identified
from
any
single
strain,
which
translates
into
silent
potential
microbial
world
production
yet
unknown
natural
products.
This
review
covers
discovery
strategies
and
innovative
methods
recently
employed
access
reservoir
The
focus
order
actinomycetes
although
approaches
similarly
applicable
microbes.
Advanced
methods,
genomics-
metagenomics-based
approaches,
as
well
modern
metabolomics-inspired
highlighted
emphasise
interplay
different
disciplines
improve
Frontiers in Microbiology,
Journal Year:
2017,
Volume and Issue:
8
Published: June 15, 2017
Actinobacteria
are
prolific
producers
of
thousands
biologically
active
natural
compounds
with
diverse
activities.
More
than
half
these
bioactive
have
been
isolated
from
members
belonging
to
actinobacteria.
Recently,
rare
actinobacteria
existing
at
different
environmental
settings
such
as
high
altitudes,
volcanic
areas,
and
marine
environment
attracted
attention.
It
has
speculated
that
physiological
or
biochemical
pressures
under
harsh
conditions
can
lead
the
production
diversified
compounds.
Hence,
focused
for
discovery
novel
products
biological
potency.
Many
promising
versatile
medicinal,
industrial,
agricultural
uses
characterized.
The
cannot
be
directly
used
drug
other
purposes,
so
they
structurally
modified
ameliorate
their
chemical
properties.
Versatile
synthetic
tools,
metabolic
engineering
techniques,
synthesis
platform
assist
structural
modification.
This
review
summarizes
latest
studies
on
focus
recent
approaches
functional
diversification
microbial
chemicals
attaining
better
applications.